Inhibrx Biosciences, Inc. (INBX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 171.34M | 132.83M | 161.42M | 193.96M | 223.39M | 160.4M | 207.45M | 242.06M | 274.54M | 295.36M | 363.3M | 203.32M |
| Cash & Short-Term Investments | 161.66M | 124.22M | 153.09M | 186.57M | 216.52M | 152.6M | 196.33M | 226.86M | 252.48M | 277.92M | 337.33M | 192.49M |
| Cash Only | 161.66M | 124.22M | 153.09M | 186.57M | 216.52M | 152.6M | 196.33M | 226.86M | 252.48M | 277.92M | 337.33M | 192.49M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 186K | 177K | 837K | 967K | 214K | 420K | 1.13M | 1.39M | 3.04M | 778K | 331K | 327K |
| Days Sales Outstanding | - | - | - | 41.34 | - | 711.62 | - | 2.01K | - | 31.22 | 254.35 | 957.02 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -331K | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 9.5M | 238K | 7.5M | 1.22M | 1.82M | 816K | 1.84M | 2.08M | 539K | 728K | 25.97M | 10.5M |
| Total Non-Current Assets | 12.63M | 13.65M | 16.05M | 18.15M | 19.25M | 20.37M | 15.12M | 16.36M | 14.04M | 12.54M | 9.44M | 9.85M |
| Property, Plant & Equipment | 8.25M | 9.27M | 10.31M | 11.35M | 12.45M | 13.54M | 8.4M | 9.62M | 9.45M | 9.37M | 6.27M | 6.68M |
| Fixed Asset Turnover | - | - | - | 0.11x | - | 0.01x | - | 0.01x | - | 0.21x | 0.02x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.38M | 4.38M | 5.74M | 6.81M | 6.8M | 6.83M | 6.71M | 6.75M | 4.59M | 3.16M | 3.16M | 3.16M |
| Total Assets | 183.97M | 146.48M | 177.47M | 212.12M | 242.64M | 180.77M | 222.56M | 258.42M | 288.58M | 307.89M | 372.73M | 213.17M |
| Asset Turnover | - | - | - | 0.01x | - | 0.00x | - | 0.00x | - | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -24.18% | -18.97% | -20.26% | -17.92% | -15.92% | -41.29% | -40.29% | 21.23% | 13.74% | 5.85% | 126.1% | 10.33% |
| Total Current Liabilities | 26.51M | 33.8M | 35.98M | 38.94M | 43.64M | 40.73M | 44.09M | 39.05M | 71.87M | 56.31M | 35.77M | 31.33M |
| Accounts Payable | 8.76M | 5.94M | 6.77M | 8.29M | 8.89M | 9.24M | 12.37M | 13.02M | 12.37M | 10.95M | 7.86M | 9.7M |
| Days Payables Outstanding | 1.23K | 1.04K | - | 1.18K | 1.21K | 1.44K | 1.54K | - | 2.95K | 2.9K | - | 3.18K |
| Short-Term Debt | 2.41M | 2.33M | 2.25M | 0 | 0 | 1.59M | 0 | 0 | 3.63M | 0 | 0 | 1.96M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 119K |
| Other Current Liabilities | 15.34M | 18.08M | 26.96M | 3.85M | 2.72M | 7.73M | 6.47M | 4.51M | 31.91M | 6.51M | 27.91M | 19.55M |
| Current Ratio | 6.46x | 3.93x | 4.49x | 4.98x | 5.12x | 3.94x | 4.70x | 6.20x | 3.82x | 5.25x | 10.16x | 6.49x |
| Quick Ratio | 6.46x | 3.93x | 4.49x | 4.98x | 5.12x | 3.94x | 4.70x | 6.20x | 3.82x | 5.25x | 10.17x | 6.49x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 178.49M | 104.69M | 104.66M | 104.62M | 104.56M | 6.45M | 0 | 0 | 205.14M | 208.08M | 207.37M | 206.65M |
| Long-Term Debt | 3.5M | 100.56M | 4.74M | 99.28M | 98.65M | 0 | 0 | 0 | 204.58M | 206.97M | 207.37M | 206.65M |
| Capital Lease Obligations | 0 | 4.13M | 0 | 5.34M | 5.9M | 6.45M | 0 | 0 | 561K | 1.11M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 174.99M | 0 | 99.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 205M | 138.49M | 140.64M | 143.56M | 148.2M | 47.18M | 44.09M | 39.05M | 277.01M | 264.39M | 243.14M | 237.98M |
| Total Debt | 5.9M | 107.01M | 6.99M | 106.79M | 106.53M | 8.05M | 1.83M | 2.17M | 210.89M | 210.14M | 207.37M | 208.61M |
| Net Debt | -155.75M | -17.21M | -146.1M | -79.78M | -109.99M | -144.55M | -194.5M | -224.69M | -41.59M | -67.78M | -129.96M | 16.12M |
| Debt / Equity | - | 13.39x | 0.19x | 1.56x | 1.13x | 0.06x | 0.01x | 0.01x | 18.23x | 4.83x | 1.60x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -8.81x | -9.71x | -10.08x | -8.12x | -15.11x | - | - | 347.58x | -8.68x | -10.74x | -5.36x | -4.95x |
| Total Equity | -21.04M | 7.99M | 36.83M | 68.56M | 94.44M | 133.58M | 178.47M | 219.37M | 11.57M | 43.5M | 129.59M | -24.81M |
| Equity Growth % | -122.27% | -94.02% | -79.36% | -68.75% | 716.42% | 207.07% | 37.71% | 984.11% | -23.56% | -25.07% | 469.74% | -404.1% |
| Book Value per Share | -1.35 | 0.52 | 2.38 | 4.43 | 6.11 | 9.23 | 11.54 | 14.82 | 0.21 | 0.81 | 2.75 | -0.57 |
| Total Shareholders' Equity | -21.04M | 7.99M | 36.83M | 68.56M | 94.44M | 133.58M | 178.47M | 219.37M | 11.57M | 43.5M | 129.59M | -24.81M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 5K | 5K | 5K | 4K |
| Retained Earnings | -279.63M | -246.19M | -213.35M | -178.1M | -149.44M | -106.13M | -58.27M | -14.4M | -692.44M | -613.73M | -520.13M | -468.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |